The role of autonomic testing in the differentiation of Parkinson's disease from multiple system atrophy

Differentiation of idiopathic Parkinson's disease (PD) from multiple system atrophy (MSA) can be difficult. Methods devised to help distinguish the two disorders include standardized autonomic testing and cardiac imaging with iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. MSA patients had more severe adrenergic and overall autonomic dysfunction when compared to control and PD patients. Area of anhidrosis on thermoregulatory sweat test was greater in MSA (67.4±12.42, p<0.001) versus PD patients (area of anhidrosis, 1.7±2.96). Postganglionic cardiac sympathetic innervation (iodine-123 meta-iodobenzylguanidine) expressed as heart to mediastinal ratio was significantly lower in Parkinson's disease patients (1.4±0.40, p=0.025) compared to controls (2.0±0.29), but not in multiple system atrophy (2.0±0.76). These findings indicate that autonomic dysfunction is generalized and predominantly preganglionic in multiple system atrophy, and postganglionic in Parkinson's disease. In our hands the thermoregulatory sweat test provides the best distinction between MSA and PD. However further confirmatory studies using larger patient numbers are required. Currently a combination of clinical judgment and autonomic testing is recommended to help differentiate MSA and PD.

[1]  S. Gilman,et al.  PET measurement of cardiac and nigrostriatal denervation in Parkinsonian syndromes. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2]  H. Reichmann,et al.  Valsalva manoeuvre in patients with different Parkinsonian disorders , 2009, Journal of Neural Transmission.

[3]  Y. Nishiyama,et al.  Abnormal cardiac [123I]‐meta‐iodobenzylguanidine uptake in multiple system atrophy , 2010, Movement disorders : official journal of the Movement Disorder Society.

[4]  K. Nakajima,et al.  Decreased myocardial 123 I‐MIBG uptake in Parkinson's disease , 1998, Acta neurologica Scandinavica.

[5]  C. Lücking,et al.  Cardiac uptake of [123I]MIBG separates Parkinson’s disease from multiple system atrophy , 1999, Neurology.

[6]  O. Rascol,et al.  Prevalence of orthostatic hypotension in Parkinson’s disease , 1997, Journal of neurology, neurosurgery, and psychiatry.

[7]  W. Weiner,et al.  American Academy of Neurology evidence-based review): Report of the Quality Standards Subcommittee of the Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an , 2007 .

[8]  P Sandroni,et al.  Second consensus statement on the diagnosis of multiple system atrophy , 2008, Neurology.

[9]  H. Reichmann,et al.  Comprehensive autonomic assessment does not differentiate between Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy , 2009, Journal of Neural Transmission.

[10]  S. Orimo,et al.  123I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[11]  J. Hughes,et al.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[12]  D. Maraganore,et al.  Influence of strict, intermediate, and broad diagnostic criteria on the age‐ and sex‐specific incidence of Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.

[13]  M. Partinen,et al.  Autonomic nervous system function in narcolepsy , 1994, Journal of sleep research.

[14]  M. Yoshita,et al.  Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy , 1998, Journal of the Neurological Sciences.

[15]  D. Riley,et al.  Autonomic nervous system testing may not distinguish multiple system atrophy from Parkinson’s disease , 2003, Journal of neurology, neurosurgery, and psychiatry.

[16]  P. Dyck,et al.  Quantitative sudomotor axon reflex test in normal and neuropathic subjects , 1983, Annals of neurology.

[17]  P A Low,et al.  Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. , 1993, Mayo Clinic proceedings.

[18]  D. Goldstein,et al.  Sympathetic cardioneuropathy in dysautonomias. , 1997, Advances in pharmacology.

[19]  W. Weiner,et al.  Practice Parameter: Diagnosis and prognosis of new onset Parkinson disease (an evidence-based review) , 2006, Neurology.

[20]  Mari Yoshida,et al.  α-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy , 2005, Acta Neuropathologica.

[21]  P. Kempster,et al.  Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. , 2008, Brain : a journal of neurology.

[22]  P. Gould.  Medical isotope shortage reaches crisis level , 2009, Nature.

[23]  T. Iwatsubo,et al.  Accumulation of phosphorylated α-synuclein in the brain and peripheral ganglia of patients with multiple system atrophy , 2004, Acta Neuropathologica.

[24]  P. Sandroni,et al.  Autonomic involvement in extrapyramidal and cerebellar disorders , 1991, Clinical Autonomic Research.

[25]  Sid Gilman,et al.  Prospective differentiation of multiple system atrophy from Parkinson disease, with and without autonomic failure. , 2009, Archives of neurology.

[26]  K. Nishigaki,et al.  Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[27]  P C O'Brien,et al.  Effect of age and gender on sudomotor and cardiovagal function and blood pressure response to tilt in normal subjects , 1997, Muscle & nerve.

[28]  Mari Yoshida,et al.  alpha-Synuclein-immunoreactive structure formation is enhanced in sympathetic ganglia of patients with multiple system atrophy. , 2005, Acta neuropathologica.

[29]  Gyeong Han Lee,et al.  MIBG scintigraphy for differentiating Parkinson's disease with autonomic dysfunction from Parkinsonism‐predominant multiple system atrophy , 2009, Movement disorders : official journal of the Movement Disorder Society.

[30]  W. Poewe,et al.  Diffusion weighted imaging best discriminates PD from MSA‐P: A comparison with tilt table testing and heart MIBG scintigraphy , 2007, Movement disorders : official journal of the Movement Disorder Society.